Article
A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.
Diabetologia - 1 Jun 2009
Schäfer S A, Müssig K, Staiger H, Machicao F, Stefan N, Gallwitz B, Häring H U, Fritsche A
Abstract excerpt
AIMS/HYPOTHESIS: WFS1 type 2 diabetes risk variants appear to be associated with impaired beta cell function, although it is unclear whether insulin secretion is affected directly or secondarily via alteration of insulin sensitivity. We aimed to investigate the effect of a common WFS1 single-nucleotide polymorphism on several aspects of insulin secretion. METHODS: A total of 1,578 non-diabetic individuals (534...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
